Exam 1 Flashcards

1
Q

Agonist

A

Activate receptor and cause a favorable conformational change that activates a second messenger cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antagonist

A

Minimal conformational change causes no second messenger cascade, no activation of receptor, prevents agonist interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inverse agonist

A

Causes alternate conformational change and a different second messenger cascade can happen or it turns the receptor off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

M1

A

parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

M2

A

Nerve terminals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

M3

A

smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nn

A

post-ganglionic cell body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nm

A

skeletal muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Full agonist

A

maximal effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Partial agonist

A

low efficacy,
reduced maximal effect,
tickles receptor,
can act as antagonist for full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antagonist efficacy

A
Competitive
No efficacy (effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Competitive antagonists

A

Bind reversibly to the receptor
Can be overcome if increase concentration of agonist
Will not alter the maximal effect of an agonist
Most common antagonist
Dynamic (binds and releases)
Increase antagonist –> decrease apparent potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Irreversible antagonist

A

Bind to the receptor in an irreversible manner
Will reduce the maximal effect of an agonist
Rare
Static
Increase irreversible –> decrease max response, and decrease apparent potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Noncompetitive antagonists

A

Bind to a site adjacent to the receptor (decrease ability of receptor to be activated by agonist)
Interfere with receptor-effector coupling mechanisms (change binding site)
Have similar effect on the agonist concentration response curve as an irreversible antagonist but is reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cellular response to an agonist

A
  1. A direct intercellular effect

2. Activation of an amplifying second messenger cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Tolerance

A
  1. Receptor desensitization
  2. Tolerance (require higher doses to get same response)
  3. Resistance
17
Q

Additive effect

A

The effect of two drugs is equal to the sum of their individual effects

18
Q

Synergistic effect

A

The effect of two drugs i greater than the sum of their individual effects

19
Q

Potentiation

A

A drug which alone has no effect enhances the potency of a drug which does have an effect

20
Q

Receptor antagonism

A

A drug with no effect inhibits effect of another drug

21
Q

Functional antagonism

A

Effect of one agonist opposes the effect of another agonist

22
Q

Median effective dose

A

Dose of drug at which 50% of individuals demonstrate the desired therapeutic effect

23
Q

Median lethal dose

A

Dose of drug causing death in 50% of subjects

24
Q

Cytarebine (Ara-C)

A

Causes DNA damage, Cancer

25
Q

Yondelis (Trabectedin)

A

Causes DNA backbone cleavage, Cancer

26
Q

Prialt (Ziconotide)

A

Selective Blocker, Pain

27
Q

Vidarabine (Ara-A)

A

Blocks viral DNA synthesis, antiviral agent

28
Q

Eribulin

A

Blocks microtubule formation, Cancer

29
Q

Bryostatin 1

A

Modulates PKC activity, failed clinical trials

30
Q

Salinosporamide A (Marizomib)

A

Irreversibly inhibits the proteosome, Cancer

31
Q

Pacleteaxel (Taxol)

A

Stabilizes microtubule dynamics, Cancer